Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: How much do patients want to know?

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 12, 2011, Pages 1628-1633

  Raphael, Claire E ^a   Koa Wing, Michael ^a   Stain, Nolan ^a   Wright, Ian ^a   Francis, Darrel P ^a   Kanagaratnam, Prapa ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

End of life; ICD deactivation; Implantable cardioverter defibrillator (ICD)

Indexed keywords

AGED; ARTICLE; DEFIBRILLATOR; DEVICE THERAPY; FEMALE; HEART FAILURE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT DECISION MAKING; TERMINALLY ILL PATIENT;

AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; TERMINAL CARE;

EID: 83555172496     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03223.x     Document Type: Article

References (21)

1. Bhatia A, Cooley R, Berger M, Blanck Z, Akhtar M,. The implantable cardiac defibrillator: Technology, indications and impact on cardiovascular survival. Curr Probl Cardiol 2004; 29: 293-356.
2. The antiarrhythmics versus implantable defibrillators (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
3. Prystowsky EN, Nisam S,. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter unsustained tachycardia trial. Multicenter automatic defibrillator implantation trial. Am J Cardiol 2000; 86: 1214-1215.
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 1999; 341: 1882-1890.
5. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ,. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001; 3: 315-322. (Pubitemid 32895839)
6. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM,. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-838. (Pubitemid 39601176)
7. Quill TE, Barold S, Sussman BL,. Discontinuing an implantable cardioverter defibrillator as a life sustaining treatment. Am J Cardiol 1994; 74: 205-206.
8. Mueller PS, Hook CC, Hayes DL,. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc 2003; 78: 959-963. (Pubitemid 36936127)
9. Pickering M, George R,. Communication: The forgotten palliative care emergency. BMJ 2007; 334: 1274.
10. Strömberg A, Jaarsma T,. Thoughts about death and perceived health status in elderly patients with heart failure. Eur J Heart Fail 2008; 10: 608-613.
11. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, Pe E, et al,. "That's like an act of suicide"-patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008; 23(S1): 7-12. (Pubitemid 350295388)
12. Goldstein NE, Mehta D, Teitelbaum E, Bradley EH, Morrison RS,. "It's like crossing a bridge" complexities preventing physicians from discussing deactivation of implantable defibrillators at the end of life. J Gen Intern Med 2008; 23:1: 2-6. (Pubitemid 350295386)
13. Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, Tsang SW, et al,. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail 2010; 16: 106-113.
14. Goldstein, N. Bradley, E. Zeidman, J. Mehta, D. Morrison, RS,. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: Results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol 2009; 54: 371-373.
15. Sherazi S, Daubert JP, Block RC, Jeevanantham V, Abdel-Gadir K, DiSalle MR, Haley JM, et al,. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008; 83: 1139-1141.
16. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Zellner R, et al,. American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine, American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; l; 7: 1008-1026.
17. Harris L., Making difficult healthcare decisions. In:, Callahan D, (ed.): What Kind of Life the Limits of Medical Progress. Washington, DC, Georgetown, University Press; 1990, pp. 5-8.
18. Stevenson LW, Hellkamp AS, Leier CV, Sopko G, Koelling T, Warnica JW, Abraham WT, et al,. Changing preferences for survival after hospitalization with advanced heart failure. J Am Coll Cardiol 2008; 52: 1702-1708.
19. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW,. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001; 20: 1016-1024. (Pubitemid 32824149)
20. Gott M, Small N, Barnes S, Payne S, Seamark D,. Older people's views of a good death in heart failure: Implications for palliative care provision. Soc Sci Med 2008; 67: 1113-1121.
21. Higgs R,. On telling patients the truth. In:, Kuhse H, Singer P, (eds.): Bioethics an Anthology. Blackwell 2001, 507-512.